CVE-2001-0117

CVE-2001-0117 is a low-severity vulnerability in Immunix with a CVSS 2.0 base score of 1.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

sdiff 2.7 in the diffutils package allows local users to overwrite files via a symlink attack.

Frequently asked questions

What is CVE-2001-0117?
sdiff 2.7 in the diffutils package allows local users to overwrite files via a symlink attack.
How severe is CVE-2001-0117?
CVE-2001-0117 has a CVSS 2.0 base score of 1.2, rated low severity.
Is CVE-2001-0117 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (29th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2001-0117?
CVE-2001-0117 primarily affects Immunix. In total, 10 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2001-0117?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2001-0117 published?
CVE-2001-0117 was published on 2001-03-12 and last updated on 2026-06-16.

References

Affected products (10)

More vulnerabilities in Immunix

All CVEs affecting Immunix →